Pten Loss and RAS/MAPK Activation Cooperate to Promote EMT and Metastasis Initiated from Prostate Cancer Stem/Progenitor Cells
Top Cited Papers
- 1 April 2012
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 72 (7), 1878-1889
- https://doi.org/10.1158/0008-5472.can-11-3132
Abstract
PTEN loss or PI3K/AKT signaling pathway activation correlates with human prostate cancer progression and metastasis. However, in preclinical murine models, deletion of Pten alone fails to mimic the significant metastatic burden that frequently accompanies the end stage of human disease. To identify additional pathway alterations that cooperate with PTEN loss in prostate cancer progression, we surveyed human prostate cancer tissue microarrays and found that the RAS/MAPK pathway is significantly elevated in both primary and metastatic lesions. In an attempt to model this event, we crossed conditional activatable K-rasG12D/WT mice with the prostate conditional Pten deletion model. Although RAS activation alone cannot initiate prostate cancer development, it significantly accelerated progression caused by PTEN loss, accompanied by epithelial-to-mesenchymal transition (EMT) and macrometastasis with 100% penetrance. A novel stem/progenitor subpopulation with mesenchymal characteristics was isolated from the compound mutant prostates, which was highly metastatic upon orthotopic transplantation. Importantly, inhibition of RAS/MAPK signaling by PD325901, a mitogen–activated protein (MAP)–extracellular signal–regulated (ER) kinase (MEK) inhibitor, significantly reduced the metastatic progression initiated from transplanted stem/progenitor cells. Collectively, our findings indicate that activation of RAS/MAPK signaling serves as a potentiating second hit to alteration of the PTEN/PI3K/AKT axis, and cotargeting both the pathways is highly effective in preventing the development of metastatic prostate cancers. Cancer Res; 72(7); 1878–89. ©2012 AACR.Other Versions
This publication has 45 references indexed in Scilit:
- Prostate Epithelial Pten/TP53 Loss Leads to Transformation of Multipotential Progenitors and Epithelial to Mesenchymal TransitionThe American Journal of Pathology, 2011
- Slow Disease Progression in a C57BL/6 Pten-Deficient Mouse Model of Prostate CancerThe American Journal of Pathology, 2011
- Cell Autonomous Role of PTEN in Regulating Castration-Resistant Prostate Cancer GrowthCancer Cell, 2011
- Phospho-MED1-enhanced UBE2C locus looping drives castration-resistant prostate cancer growthThe EMBO Journal, 2011
- Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistanceNature Medicine, 2010
- Integrative Genomic Profiling of Human Prostate CancerCancer Cell, 2010
- Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signatureClinical & Experimental Metastasis, 2009
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008
- Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formationNature, 2008
- Oncogenic pathway signatures in human cancers as a guide to targeted therapiesNature, 2005